Radioligand Therapy (RLT) Market to Reach USD 10.91 Billion by 2035 — Transforming Precision Oncology
The global Radioligand Therapy (RLT) market is witnessing strong growth momentum, driven by technological innovation, expanding indications, and increasing global access to targeted radiotherapies. Valued at USD 2.36 billion in 2024, the market is projected to rise to USD 3.15 billion in 2025, and advance at a CAGR of 13.2% from 2025 to 2035, reaching an impressive USD 10.91 billion by the end of...